Oncology Research

Papers
(The TQCC of Oncology Research is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Has_circ_0000069 expression in breast cancer and its influences on prognosis and cellular activities53
Comprehensively analyzing the genetic alterations, and identifying key genes in ovarian cancer48
Construction of the panoptosis-related gene model and characterization of tumor microenvironment infiltration in hepatocellular carcinoma43
System analysis based on the T cell exhaustion‑related genes identifies CD38 as a novel therapy target for ovarian cancer38
A novel isoxazole compound CM2-II-173 inhibits the invasive phenotype of triple-negative breast cancer cells36
Long non-coding RNA H19 promotes proliferation in hepatocellular carcinoma cells via H19/miR-107/CDK6 axis34
The role of AFAP1-AS1 in mitotic catastrophe and metastasis of triple-negative breast cancer cells by activating the PLK1 signaling pathway30
The role of LIN28B in tumor progression and metastasis in solid tumor entities28
Prognostic-related genes for pancreatic cancer typing and immunotherapy response prediction based on single-cell sequencing data and bulk sequencing data28
Betulinic acid-mediating miRNA-365 inhibited the progression of pancreatic cancer19
Changes of protein expression during tumorosphere formation of small cell lung cancer circulating tumor cells19
Neoadjuvant intermediate-course versus long-course chemoradiotherapy in T3-4/N0+ rectal cancer: Istanbul R-02 phase II randomized study18
mTORC2 promotes pancreatic cancer progression and parp inhibitor resistance17
Identification of lncRNAs associated with T cells as potential biomarkers and therapeutic targets in lung adenocarcinoma16
YWHAH activates the HMGA1/PI3K/AKT/mTOR signaling pathway by positively regulating Fra-1 to affect the proliferation of gastric cancer cells15
Targeting DNA repair for cancer treatment: Lessons from PARP inhibitor trials15
Deoxynortryptoquivaline: A unique antiprostate cancer agent14
Multi-institutional analysis of cervical esophageal carcinoma patients treated with definitive chemoradiotherapy: TROD 01-005 study13
The anti-oncogenic effect of 17-DMAG via the inactivation of HSP90 and MET pathway in osteosarcoma cells13
A pan-cancer analysis identifies SOAT1 as an immunological and prognostic biomarker13
Drug repositioning of disulfiram induces endometrioid epithelial ovarian cancer cell death via the both apoptosis and cuproptosis pathways13
0.054764032363892